Lellouche, L.; Barat, M.; Pellat, A.; Leroux, J.; Corre, F.; Hallit, R.; Assaf, A.; Brezault, C.; Dhooge, M.; Soyer, P.;
et al. Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma. J. Clin. Med. 2023, 12, 2211.
https://doi.org/10.3390/jcm12062211
AMA Style
Lellouche L, Barat M, Pellat A, Leroux J, Corre F, Hallit R, Assaf A, Brezault C, Dhooge M, Soyer P,
et al. Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma. Journal of Clinical Medicine. 2023; 12(6):2211.
https://doi.org/10.3390/jcm12062211
Chicago/Turabian Style
Lellouche, Lisa, Maxime Barat, Anna Pellat, Juliette Leroux, Felix Corre, Rachel Hallit, Antoine Assaf, Catherine Brezault, Marion Dhooge, Philippe Soyer,
and et al. 2023. "Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma" Journal of Clinical Medicine 12, no. 6: 2211.
https://doi.org/10.3390/jcm12062211
APA Style
Lellouche, L., Barat, M., Pellat, A., Leroux, J., Corre, F., Hallit, R., Assaf, A., Brezault, C., Dhooge, M., Soyer, P., & Coriat, R.
(2023). Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma. Journal of Clinical Medicine, 12(6), 2211.
https://doi.org/10.3390/jcm12062211